🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hsin-Hui Huang

AbbVie (United States)

ORCID: 0000-0001-7160-5179

Also affiliated with National Cheng Kung University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
5.6Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

CIDO, a community-based ontology for coronavirus disease knowledge and data integration, sharing, and analysis

Scientific Data(2020)10.1038/s41597-020-0523-6
Top 4%
5.0DataRank
Top 4%133 citations

Hong Yu, Edison Ong, Yang Wang, Yingtong Liu, Anthony Huffman +9 more

Papers

Driven by 12 papers — median percentile 70. Top paper: “An inflammatory cytokine signature predicts COVID-19 severity and survival”.

An inflammatory cytokine signature predicts COVID-19 severity and survival

Nature Medicine(2020)10.1038/s41591-020-1051-9
N/A
14.0DataRank · unranked
2749 citations

Seunghee Kim‐Schulze, Hsin-Hui Huang, Noam D. Beckmann, Sharon Nirenberg, Bo Wang +27 more

CIDO, a community-based ontology for coronavirus disease knowledge and data integration, sharing, and analysis

Scientific Data(2020)10.1038/s41597-020-0523-6
Top 4%
5.0DataRank
Top 4%133 citations

Hong Yu, Edison Ong, Yang Wang, Yingtong Liu, Anthony Huffman +9 more

Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn’s Disease

Gastroenterology(2022)10.1053/j.gastro.2022.05.029
N/A
1.9DataRank · unranked
69 citations

Romain Remark, Diane M. Del Valle, Ling-Shiang Chuang, Zhi Chai, Inês Alves +30 more

A comprehensive update on CIDO: the community-based coronavirus infectious disease ontology

Journal of Biomedical Semantics(2022)10.1186/s13326-022-00279-z
Top 30%
0.668DataRank
Top 30%24 citations

Hong Yu, Anthony Huffman, Yu Lin, Darren A. Natale, John Beverley +38 more

Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-0251
N/A
0.564DataRank · unranked
42 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more

A new framework for host-pathogen interaction research

Frontiers in Immunology(2022)10.3389/fimmu.2022.1066733
N/A
0.434DataRank · unranked
17 citations

Li Li, Anthony Huffman, John Beverley, Junguk Hur, Eric Merrell +22 more

Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0252
N/A
0.208DataRank · unranked
3 citations

Hsin-Hui Huang, Opeyemi A. Jagede, Kevin Tuballes, Diane M. Del Valle, Geoffrey Kelly +19 more

Multiethnic Investigation of Risk and Immune Determinants of COVID-19 Outcomes

Frontiers in Cellular and Infection Microbiology(2022)10.3389/fcimb.2022.933190
N/A
0.165DataRank · unranked
2 citations

Divij Mathew, Navya Sharma, Sharon Nirenberg, Hsin-Hui Huang, Patricia Kovatch +3 more

Dynamic changes in serum analyte levels associated with clinical outcome in squamous cell lung cancer trial SWOG Lung-MAP S1400I of nivolumab ± ipilimumab.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9044
N/A
0DataRank · unranked
0 citations

Hsin-Hui Huang, Mary W. Redman, Roy S. Herbst, Scott Gettinger, Lyudmila Bazhenova +15 more

Factors associated with U.S. hospital payer-specific negotiated mammography charges.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e13633
N/A
0DataRank · unranked
0 citations

Hsin-Hui Huang, Elizabeth S. Tarras, Ellerie Weber, Deborah Marshall, Kristin Hsieh

Multi-ethnic Investigation of Risk and Immune Determinants of COVID-19 Outcomes

Research Square(2022)10.21203/rs.3.rs-1055587/v1
N/A
0DataRank · unranked
0 citations

Divij Mathew, Navya Sharma, Sharon Nirenberg, Hsin-Hui Huang, Patricia Kovatch +3 more

Data from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

(2024)10.1158/1078-0432.c.7181344.v1
Top 100%
0DataRank
Top 100%0 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more